Pneumococcal 23-valent vaccine (Sinovac Biotech)
- Generic Name
- Pneumococcal 23-valent vaccine (Sinovac Biotech)
A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)
Phase 2
Active, not recruiting
- Conditions
- DiphtheriaTetanusPertussis
- Interventions
- Biological: Tetanus, Reduced Diphtheria and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp))Biological: 23-valent Pneumococcal Polysaccharide Vaccine (PPV23)Biological: Diphtheria-tetanus-acellular pertussis vaccine (DTaP)
- First Posted Date
- 2024-11-27
- Last Posted Date
- 2025-03-17
- Lead Sponsor
- CanSino Biologics Inc.
- Target Recruit Count
- 1820
- Registration Number
- NCT06708286
- Locations
- 🇨🇳
Kaihua County Center for Disease Control and Prevention, Kaihua, China
Clinical Trial of Recombinant Pneumococcal Protein Vaccine
Phase 1
Completed
- Conditions
- PneumoniaRespiratory Tract InfectionsRespiratory Tract Diseases
- Interventions
- First Posted Date
- 2022-11-21
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- CanSino Biologics Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT05622942
- Locations
- 🇨🇳
Lancang Lahu Autonomous County Center for Disease Control and Prevention, Puer, Yunnan, China
Safety, Tolerability, and Immunogenicity of V110 or V114 Co-administered With a Booster Dose of mRNA-1273 in Healthy Adults (V110-911)
Phase 3
Completed
- Conditions
- Pneumococcal Infection
- Interventions
- Biological: Placebo for V110Biological: Placebo for V114
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- Merck Sharp & Dohme LLC
- Target Recruit Count
- 850
- Registration Number
- NCT05158140
- Locations
- 🇺🇸
Valley Clinical Trials Inc. ( Site 0002), Northridge, California, United States
🇵🇷CAIMED Center - Ponce School of Medicine ( Site 0103), Ponce, Puerto Rico
🇺🇸Charlottesville Medical Research Center, LLC ( Site 0008), Charlottesville, Virginia, United States
Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2023-12-01
- Lead Sponsor
- Jena University Hospital
- Target Recruit Count
- 123
- Registration Number
- NCT02637583
- Locations
- 🇩🇪
Center of Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath